Literature DB >> 8786968

Transport of a hydrophilic compound into the cerebrospinal fluid during experimental allergic encephalomyelitis and after lipopolysaccharide administration.

H E de Vries1, E F Eppens, M Prins, J Kuiper, T J van Berkel, A G de Boer, D D Breimer.   

Abstract

PURPOSE: The transport of the hydrophilic model compound sodium fluorescein into the cerebrospinal fluid (CSF) of rats was studied during experimental allergic encephalomyelitis (EAE), as a model for local central nervous system (CNS) inflammatory disease, and after a single injection of a pyrogenic dose of lipopolysaccharide (LPS), as a model for a general inflammation.
METHODS: Transport of sodium fluorescein was measured by means of serial CSF and plasma sampling. Transport of this hydrophilic model compound was studied in Lewis rats suffering from EAA and three hours after LPS administration in male Wistar rats.
RESULTS: During acute EAE, sodium fluorescein concentrations in the CSF increased twofold compared to control animals, whereas plasma kinetics were comparable within both groups. After i.v. LPS administration, however, plasma as well as CSF kinetic parameters of sodium fluorescein concentration were significantly changed from those seen in control animals. Transport of sodium fluorescein from plasma into the CSF was calculated as the ratio Area Under the Curve (AUC)CSF/AUCPLASMA. During acute EAE this ratio increased 2-fold compared to control animals, whereas after i.v. LPS administration it was not significantly different from the one obtained in control animals.
CONCLUSIONS: These results suggest an opening of the blood-brain barrier (BBB) during a cerebral inflammatory response, like acute EAE, but not after LPS administration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786968     DOI: 10.1023/a:1016291806357

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

Review 1.  Pathophysiological aspects of acute experimental allergic encephalomyelitis.

Authors:  M Juhler
Journal:  Acta Neurol Scand Suppl       Date:  1988

Review 2.  The blood-brain barrier and multiple sclerosis.

Authors:  A C Moor; H E de Vries; A G de Boer; D D Breimer
Journal:  Biochem Pharmacol       Date:  1994-05-18       Impact factor: 5.858

3.  Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?

Authors:  B Jeppsson; H R Freund; Z Gimmon; J H James; M F von Meyenfeldt; J E Fischer
Journal:  Am J Surg       Date:  1981-01       Impact factor: 2.565

4.  Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.

Authors:  M A Hurni; A B Noach; M C Blom-Roosemalen; A G de Boer; J F Nagelkerke; D D Breimer
Journal:  J Pharmacol Exp Ther       Date:  1993-11       Impact factor: 4.030

Review 5.  Response of man to endotoxin.

Authors:  G D Martich; A J Boujoukos; A F Suffredini
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

6.  Relation between the increase in the diffusional permeability of the blood-central nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat.

Authors:  P M Daniel; D K Lam; O E Pratt
Journal:  J Neurol Sci       Date:  1983 Aug-Sep       Impact factor: 3.181

7.  Development and application of a radioimmunoassay to detect interleukin-1 in rat peripheral circulation.

Authors:  R Derijk; F Berkenbosch
Journal:  Am J Physiol       Date:  1992-12

Review 8.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  Blood-brain barrier permeability changes during acute allergic encephalomyelitis induced in the guinea pig.

Authors:  B V Zlokovic; D S Skundric; M B Segal; J Colover; R M Jankov; N Pejnovic; V Lackovic; J Mackic; M N Lipovac; H Davson
Journal:  Metab Brain Dis       Date:  1989-03       Impact factor: 3.584

10.  E. coli peritonitis and bacteremia cause increased blood-brain barrier permeability.

Authors:  G C du Moulin; D Paterson; J Hedley-Whyte; S A Broitman
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

View more
  2 in total

Review 1.  Blood-brain barrier dysfunction and recovery.

Authors:  A G de Boer; P J Gaillard
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

2.  Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system.

Authors:  Denis Soulet; Serge Rivest
Journal:  J Cell Biol       Date:  2003-07-14       Impact factor: 10.539

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.